Inovio Pharmaceuticals, a developer of therapeutic and preventive vaccines against cancers and infectious diseases, has named Dr. Avtar Dhillon non-executive chairman of the board of directors.

Dr. Dhillon was appointed executive chairman of the board in 2009 in conjunction with the merger between Inovio Biomedical and VGX Pharmaceuticals with a mandate to provide continuity and strategic guidance during their integration. Dr. Dhillon will now focus on his role as chairman and will no longer have executive responsibilities.